Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 135357, 7 pages
http://dx.doi.org/10.1155/2014/135357
Clinical Study

Prognostic Value of VEGF in Patients Submitted to Percutaneous Coronary Intervention

1Instituto de Biociências e Bioengenharia (IBB), Instituto Superior Técnico, Universidade de Lisboa, Avenida Rovisco Pais 1, 1049-001 Lisboa, Portugal
2Serviço de Cardiologia, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, 1069-024 Lisboa, Portugal
3Carlota Saldanha Lab, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal
4CESAM, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisboa, Portugal
5CEDOC, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal

Received 21 February 2014; Revised 17 June 2014; Accepted 20 June 2014; Published 7 July 2014

Academic Editor: Luisella Bocchio-Chiavetto

Copyright © 2014 Catarina Ramos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Carmeliet and R. K. Jain, “Molecular mechanisms and clinical applications of angiogenesis,” Nature, vol. 473, no. 7347, pp. 298–307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Simons, “An inside view: VEGF receptor trafficking and signaling,” Physiology, vol. 27, no. 4, pp. 213–222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. R. Horowitz, A. Rivard, R. van der Zee et al., “Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension: Evidence for a maintenance role in quiescent adult endothelium,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 11, pp. 2793–2800, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Zachary, “Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor,” American Journal of Physiology—Cell Physiology, vol. 280, no. 6, pp. C1375–C1386, 2001. View at Google Scholar · View at Scopus
  5. Z. Chang, L. Hong, H. Wang, H. Lai, L. Li, and Q. Yin, “Application of peripheral-blood-derived endothelial progenitor cell for treating ischemia-reperfusion injury and infarction: a preclinical study in rat models,” Journal of Cardiothoracic Surgery, vol. 8, no. 1, article 33, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Vestweber, “VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 2, pp. 223–232, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. N. G. dela Paz, T. E. Walshe, L. L. Leach, M. Saint-Geniez, and P. A. D’Amore, “Role of shear-stress-induced VEGF expression in endothelial cell survival,” Journal of Cell Science, vol. 125, no. 4, pp. 831–843, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. T. E. Walshe, V. S. Dole, A. S. R. Maharaj, I. S. Patten, D. D. Wagner, and P. A. D’Amore, “Inhibition of VEGF or TGF-β signaling activates endothelium and increases leukocyte rolling,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 8, pp. 1185–1192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Lee, T. T. Chen, C. L. Barber et al., “Autocrine VEGF Signaling Is Required for Vascular Homeostasis,” Cell, vol. 130, no. 4, pp. 691–703, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. D. O. Bates, “Vascular endothelial growth factors and vascular permeability,” Cardiovascular Research, vol. 87, no. 2, pp. 262–271, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. P. Maloney, C. C. Silliman, D. R. Ambruso, J. Wang, R. M. Tuder, and N. F. Voelkel, “In vitro release of vascular endothelial growth factor during platelet aggregation,” American Journal of Physiology. Heart and Circulatory Physiology, vol. 275, no. 3, pp. H1054–H1061, 1998. View at Google Scholar · View at Scopus
  12. S. H. Lee, P. L. Wolf, R. Escudero, R. Deutsch, S. W. Jamieson, and P. A. Thistlethwaite, “Early expression of angiogenesis factors in acute myocardial ischemia and infarction,” The New England Journal of Medicine, vol. 342, no. 9, pp. 626–633, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Cotton, A. Mathur, Y. Hong, A. S. Brown, J. F. Martin, and J. D. Erusalimsky, “Acute rise of circulating vascular endothelial growth factor-A in patients with coronary artery disease following cardiothoracic surgery,” European Heart Journal, vol. 23, no. 12, pp. 953–959, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Heeschen, S. Dimmeler, C. W. Hamm, E. Boersma, A. M. Zeiher, and M. L. Simoons, “Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes,” Circulation, vol. 107, no. 4, pp. 524–530, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Korybalska, M. Pyda, E. Kawka, S. Grajek, A. Breborowicz, and J. Witowski, “Interpretation of elevated serum VEGF concentrations in patients with myocardial infarction,” Cytokine, vol. 54, no. 1, pp. 74–78, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S.-Y. Kim, S.-H. Lee, S. Park et al., “Vascular endothelial growth factor, soluble Fms-like tyrosine kinase 1, and the severity of coronary artery disease,” Angiology, vol. 62, no. 2, pp. 176–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Kranz, C. Rau, M. Kochs, and J. Waltenberger, “Elevation of vascular endothelial growth factor A serum levels following acute myocardial infarction. Evidence for its origin and functional significance,” Journal of Molecular and Cellular Cardiology, vol. 32, no. 1, pp. 65–72, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Banerjee, E. Brilakis, S. Zhang et al., “Endothelial progenitor cell mobilization after percutaneous coronary intervention,” Atherosclerosis, vol. 189, no. 1, pp. 70–75, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. G. E. Kochiadakis, M. E. Marketou, D. Panutsopulos et al., “Vascular endothelial growth factor protein levels and gene expression in peripheral monocytes after stenting: a randomized comparative study of sirolimus: eluting and bare metal stents,” European Heart Journal, vol. 29, no. 6, pp. 733–740, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Gill, S. Dias, K. Hattori et al., “Vascular trauma induces rapid but transient mobilization of VEGFR2+ AC133+ endothelial precursor cells,” Circulation Research, vol. 88, no. 2, pp. 167–174, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. J. S. Silvestre, D. M. Smadja, and B. I. Lévy, “Postischemic revascularization: from cellular and molecular mechanisms to clinical applications,” Physiological Reviews, vol. 93, no. 4, pp. 1743–1802, 2013. View at Google Scholar
  22. H. F. Alber, M. Frick, J. Dulak et al., “Vascular endothelial growth factor (VEGF) plasma concentrations in coronary artery disease,” Heart, vol. 91, no. 3, pp. 365–366, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. C. B. Eaton, R. Gramling, D. R. Parker, M. B. Roberts, B. Lu, and P. M. Ridker, “Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in Southeastern New England,” Atherosclerosis, vol. 200, no. 1, pp. 221–227, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. B. H. Kim, Y. Ko, A. Her et al., “Serial plasma levels of angiogenic factors in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention,” Korean Circulation Journal, vol. 42, no. 7, pp. 464–470, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Uhlemann, V. Adams, K. Lenk et al., “Impact of different exercise training modalities on the coronary collateral circulation and plaque composition in patients with significant coronary artery disease (EXCITE trial): study protocol for a randomized controlled trial,” Trials, vol. 13, article 167, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Sandri, V. Adams, S. Gielen et al., “Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies,” Circulation, vol. 111, no. 25, pp. 3391–3399, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. A. N. Mischie, M. S. Nazzaro, R. Fiorilli et al., “Head-to-head comparison of sirolimus-eluting stent versus bare metal stent evaluation of the coronary endothelial dysfunction in the same patient presenting with multiple coronary artery lesions: the CREDENTIAL study,” Catheterization and Cardiovascular Interventions, vol. 82, no. 3, pp. E184–E191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. L. K. Pendyala, X. Yin, J. Li, J. P. Chen, N. Chronos, and D. Hou, “The first-generation drug-eluting stents and coronary endothelial dysfunction,” JACC: Cardiovascular Interventions, vol. 2, no. 12, pp. 1169–1177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. M. G. Lampugnani, A. Zanetti, M. Corada et al., “Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, β-catenin, and the phosphatase DEP-1/CD148,” Journal of Cell Biology, vol. 161, no. 4, pp. 793–804, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Gampel, L. Moss, M. C. Jones, V. Brunton, J. C. Norman, and H. Mellor, “VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endothelial storage compartment,” Blood, vol. 108, no. 8, pp. 2624–2631, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Wallez, F. Cand, F. Cruzalegui et al., “Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site,” Oncogene, vol. 26, no. 7, pp. 1067–1077, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Mattila, K. Auvinen, M. Salmi, and J. Ivaska, “The protein tyrosine phosphatase TCPTP controls VEGFR2 signalling,” Journal of Cell Science, vol. 121, no. 21, pp. 3570–3580, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. P. M. Lacal, V. Morea, F. Ruffini et al., “Inhibition of endothelial cell migration and angiogenesis by a vascular endothelial growth factor receptor-1 derived peptide,” European Journal of Cancer, vol. 44, no. 13, pp. 1914–1921, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Ahmad, P. W. Hewett, B. Al-Ani et al., “Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis,” Cell, vol. 3, p. 15, 2011. View at Google Scholar
  35. G. S. Di Marco, S. Reuter, U. Hillebrand et al., “The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD,” Journal of the American Society of Nephrology, vol. 20, no. 10, pp. 2235–2245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Jelkmann, “Pitfalls in the measurement of circulating vascular endothelial growth factor,” Clinical Chemistry, vol. 47, no. 4, pp. 617–623, 2001. View at Google Scholar · View at Scopus